Research study Program year 2020 Source: CMS Open Payments

RSV Oa=Adj-002

Research payments

$5,166,831

1,269 payments

Through program year 2020, $5,166,831 in research payments was reported against RSV Oa=Adj-002, across 1,269 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$1,334,255	478
2019	Research	$3,832,576	791

Breakdown

Who paid Research payments · program years 2019–2020

GlaxoSmithKline, LLC. $5,166,831 1,269 payments

Who received the money Research payments · program years 2019–2020

Rochester Clinical Research Organisation paid for research $1,311,160 116 payments
Alliance For Multispecialty Research Organisation paid for research $688,782 266 payments
Johnson County Clinic Trials Organisation paid for research $663,198 103 payments
Meridian Clinical Research LLC Organisation paid for research $536,187 93 payments
Pmg Research Organisation paid for research $431,722 113 payments
Texas Center For Drug Development Organisation paid for research $225,255 65 payments
Center For Clinical Research Organisation paid for research $203,437 58 payments
Clinical Research Institute Of Southern Oregon Pc Organisation paid for research $151,412 50 payments
Benchmark Research Organisation paid for research $146,395 57 payments
Spartanburg Medical Research Organisation paid for research $139,025 69 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.